|
Volumn 88, Issue 12, 2003, Pages 1366-1371
|
A pilot study of CODOX-M/IVAC in primary refractory or relapsed high-grade non-Hodgkin's lymphoma. A Scotland and Newcastle Lymphoma Group Study
|
Author keywords
CODOX M IVAC regimen; High grade NHL; Relapse refractory patients; Salvage therapy
|
Indexed keywords
ANTIBIOTIC AGENT;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DOXORUBICIN;
EPIRUBICIN;
ETOPOSIDE;
FOLINIC ACID;
IFOSFAMIDE;
MELPHALAN;
MESNA;
METHOTREXATE;
PREDNISOLONE SODIUM PHOSPHATE;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
VINCRISTINE;
ADOLESCENT;
ADULT;
ARTICLE;
AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION;
BONE MARROW SUPPRESSION;
CANCER COMBINATION CHEMOTHERAPY;
CANCER PATIENT;
CANCER RECURRENCE;
CHEMOSENSITIVITY;
CHEMOTHERAPY INDUCED EMESIS;
CLINICAL PROTOCOL;
CONJUNCTIVITIS;
DRUG FORMULATION;
FEMALE;
HUMAN;
LASSITUDE;
MAJOR CLINICAL STUDY;
MALE;
MUCOSA INFLAMMATION;
NAUSEA;
NEUROTOXICITY;
NONHODGKIN LYMPHOMA;
PERIPHERAL BLOOD STEM CELL TRANSPLANTATION;
PILOT STUDY;
PROGNOSIS;
REFRACTORY PERIOD;
RELAPSE;
SALVAGE THERAPY;
SEPSIS;
SIDE EFFECT;
STOMATITIS;
TREATMENT OUTCOME;
UNITED KINGDOM;
ADULT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
COMBINED MODALITY THERAPY;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DISEASE PROGRESSION;
DOXORUBICIN;
DRUG ADMINISTRATION SCHEDULE;
ETOPOSIDE;
FEMALE;
GRANULOCYTE COLONY-STIMULATING FACTOR;
HEMATOPOIETIC STEM CELL MOBILIZATION;
HUMANS;
IFOSFAMIDE;
INJECTIONS, SPINAL;
LEUCOVORIN;
LYMPHOMA, HIGH-GRADE;
LYMPHOMA, NON-HODGKIN;
MALE;
MESNA;
METHOTREXATE;
MIDDLE AGED;
PERIPHERAL BLOOD STEM CELL TRANSPLANTATION;
PILOT PROJECTS;
PROGNOSIS;
RECOMBINANT PROTEINS;
SALVAGE THERAPY;
SEPSIS;
TREATMENT OUTCOME;
VINCRISTINE;
|
EID: 0346733122
PISSN: 03906078
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (8)
|
References (10)
|